General Information of Drug Transporter (DT)
DT ID DTD0286 Transporter Info
Gene Name SLC34A3
Transporter Name Sodium-dependent phosphate transport protein 2C
Gene ID
142680
UniProt ID
Q8N130
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  aristolochic acid I

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aristolochic acid I results in increased expression of SLC34A3 mRNA [3]

Regulation Mechanism

Transcription Factor Info

  Cyclosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine results in decreased methylation of SLC34A3 promoter [4]

Regulation Mechanism

Transcription Factor Info

  Phosphates

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

SLC34A3 protein affects the transport of Phosphates co-treated with Sodium [5]

Regulation Mechanism

Transcription Factor Info

  picene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

picene results in increased expression of SLC34A3 mRNA [6]

Regulation Mechanism

Transcription Factor Info

  Sodium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

SLC34A3 protein affects the transport of Phosphates co-treated with Sodium [5]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in decreased expression of SLC34A3 mRNA [2]

Regulation Mechanism

Transcription Factor Info

Natural Product

  Resveratrol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Plant Extracts co-treated with Resveratrol results in decreased expression of SLC34A3 mRNA [7]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Sunitinib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sunitinib increases the expression of SLC34A3 [1]

Drug in Phase 1 Trial

  Sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium arsenite inhibits the expression of SLC34A3 [2]
References
1 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
2 Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. Arch Toxicol. 2021 Jul;95(7):2351-2365.
3 Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. Toxicol In Vitro. 2021;70:105054.
4 Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
5 Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2006;78(2):193-201.
6 Indeno[1,2,3-cd]pyrene and picene mediate actions via estrogen receptor signaling pathway in in vitro cell systems, altering gene expression. Toxicol Appl Pharmacol. 2020;396:114995.
7 One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res. 2013;72:69-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.